Tore Hopen, CEO of Farvatn Private Equity, believes in Hyperthermics' unique approach to converting waste into climate-neutral energy and proteins. (Photo: Hans J. Brun)

Farvatn Private Equity and Måsøval Eiendom join the biotechnology company Hyperthermics AS. - This is a good match, says Erlend Haugsbø in Hyperthermics.

Hyperthermics' technology is based on hyperthermophilic bacteria to degrade biomass for biogas and protein production. The bacteria's high working temperature speeds up decomposition and increases the capacity of the production facilities. The main markets are biogas producers and fish farmers.

- Both Farvatn and Måsøval are involved in aquaculture and fish farming, says Erlend Haugsbø, CEO of Hyperthermics AS. - The aquaculture industry is investing heavily in becoming greener, and our solutions contribute, among other things, to transforming fish sludge into a valuable resource.

Haugsbø points out that many of the shareholders in the company are involved in biogas production or fish farming: - This means that they have a great interest in the successful commercialization of the technology of Hyperthermics.

Tore Hopen, CEO of Farvatn Private Equity, explains the investment as follows: - Climate, environment, and energy are very relevant topics. We believe in Hyperthermics' unique approach to converting waste into climate-neutral energy and proteins.

Farvatn and Måsøval hold approximately 11% of the shares in Hyperthermics AS. It is a mark of quality for Hyperthermics that shareholders such as Farvatn and Måsøval enter the ownership side of the company. Such shareholders help to strengthen the commercialization of Hyperthermics' technology.